AOD-9604 — Targeted Fat-Loss Peptide

Lipolysis activation • Fat-cell reduction • Metabolic support

AOD-9604 is a modified fragment of human growth hormone engineered specifically to target fat metabolism — without stimulating overall growth hormone or IGF-1 levels. This makes it a unique compound in metabolic research because it delivers the fat-burning effects of GH without the anabolic or endocrine impact.

In research and clinical environments, AOD-9604 has been shown to:

• Stimulate lipolysis (fat breakdown) • Inhibit lipogenesis (new fat storage) • Target stubborn fat deposits • Support metabolic efficiency • Reduce fat cell size and number

Unlike GLP-1 peptides that suppress appetite, AOD-9604 works by directly signaling fat cells to release stored energy, making it a powerful tool in body-recomposition and fat-loss research.

Why AOD-9604 is different

AOD-9604 does not affect hunger, insulin, or hormones — it communicates directly with fat tissue.

By activating the same lipolytic pathways as growth hormone, it allows the body to:

• Mobilize stubborn fat • Prevent new fat formation • Improve body composition • Enhance metabolic output

This makes it especially valuable in plateau-breaking and visceral fat research.

Used in research to study

• Obesity and metabolic dysfunction • Fat-cell signaling • Body recomposition • Lipid metabolism • Weight-management strategies

PHP™ Research Performance Standard

Our AOD-9604 is supplied as a research-grade lyophilized peptide produced in GMP-certified facilities and verified for:

✔ Identity ✔ Purity ✔ Potency ✔ Endotoxin levels

Because real performance starts at the cellular level. Pure Science. Raw Power.